Article
Ridgefield, CT—Eschenbach Optik of America Inc. is changing its senior management team with the promotion of its ophthalmic division president to company president.
Advanced therapies for retinal vascular diseases
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Glaucoma 360 offering cutting-edge innovations and networking opportunities